FDA approves 'potential blockbuster' migraine jab from Lundb...

The FDA has approved Lundbeck’s eptinezumab prophylactic treatment for migraine, the last from a gang of four drugs from a new class.

After rejection, NICE agrees to look again at migraine drug ...

FDA approves Allergan's migraine tablet ahead of AbbVie merg...

Allergan’s migraine tablet Ubrelvy (ubrogepant) has been approved in the US for the acute treatment of patients with or without aura.

Allergan builds case for migraine drug ubrogepant as FDA ver...

FDA approves Lilly's new migraine attack drug, rival from Al...

The FDA has approved Eli Lilly’s new migraine drug lasmiditan, offering patients a new option to relieve symptoms should they feel an attack coming on.

Blow to Novartis as NICE rejects migraine drug Aimovig again